Results 1 to 6 of 6
Page 1 of 1
TypeTitleAuthor(s)YearViews
High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis BLin, CL; Tsai, SL; Lee, TH; Chien, RN; Liao, SK; Liaw, YF2005195
 
Four years of lamivudine treatment in Chinese patients with chronic hepatitis BChang, TT; Lai, CL; Chien, RN; Guan, R; Lim, SG; Lee, CM; Ng, KY; Nicholls, GJ; Dent, JC; Leung, NWY2004136
 
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapyLeung, NWY; Lai, CL; Chang, TT; Guan, R; Lee, CM; Ng, KY; Lim, SG; Wu, PC; Dent, JC; Edmundson, S; Condreay, LD; Chien, RN200182
 
Effects of extended lamivudine therapy in asian patients with chronic hepatitis BLiaw, YF; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Chien, RN; Dent, J; Roman, L; Edmundson, S; Lai, CL200067
 
Lamivudine for chronic hepatitis B [2] (multiple letters)Bernasconi, E; Battegay, M; Lai, CL; Chien, RN; Leung, NWY199846
 
A one-year trial of lamivudine for chronic hepatitis BLai, CL; Chien, RN; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Wu, PC; Dent, JC; Barber, J; Stephenson, SL; Gray, DF1998314
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download